Ursodeoxycholic acid in pregnancy?

Elsemieke de Vries, Ulrich Beuers

Research output: Contribution to journalReview articleAcademicpeer-review

26 Citations (Scopus)

Abstract

The case of a 34-year-old woman with primary biliary cholangitis (PBC) before, during and after pregnancy is described. The use of ursodeoxycholic acid (UDCA) during and after pregnancy is discussed. UDCA has not been approved by the drug regulatory authorities as a pregnancy-safe drug; therefore, the reluctance of clinicians to prescribe UDCA during pregnancy is understandable. This Grand Round aims to provide a detailed analysis of the current evidence, safety data and clinical experience with UDCA (and alternative drugs) during pregnancy and lactation. Based on this analysis, advice for clinicians regarding the use of UDCA during pregnancy and lactation is given.
Original languageEnglish
Pages (from-to)1237-1245
JournalJournal of Hepatology
Volume71
Issue number6
DOIs
Publication statusPublished - 2019

Cite this